指南与共识神经MR

2021年MAGNIMS-CMSC-NAIMS关于多发性硬化患者MRI使用的共识建议

2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.
指南 / 共识 · Lancet Neurol · 2021-06-14

该2021年修订版共识由MAGNIMS、CMSC与NAIMS联合制定,将2017年McDonald诊断标准修订、钆对比剂安全性顾虑及脊髓MRI价值等进展转化为临床实践,提出以三维液体衰减反转恢复序列为核心脑部脉冲序列,并给出钆对比剂审慎使用、儿童、妊娠及产后患者MRI应用的建议。

要点

  • 推荐三维液体衰减反转恢复序列作为核心脑部脉冲序列,以提高诊断准确性和识别新病灶的能力。
  • 对钆对比剂的使用给出针对特定临床目的的审慎使用建议。
  • 建议将MRI应用扩展至儿童、妊娠及产后多发性硬化患者。

核心结论

  • 2021年修订版共识将研究进展转化为临床实践,以改进MRI在多发性硬化诊断、预后和监测中的应用。

研究设计与样本

  • 本共识由MAGNIMS研究组、CMSC与NAIMS联合制定,合并三方建议并纳入2017年McDonald诊断标准修订等进展。

诊断标准与关键数值

  • 推荐强调三维液体衰减反转恢复序列作为核心脑部脉冲序列,以提高诊断准确性及识别新病灶以监测治疗有效性的能力。
  • 提供针对特定临床目的审慎使用钆对比剂的建议。
  • 将建议扩展至儿童、妊娠及产后多发性硬化患者的MRI使用。

临床应用与阅片要点

  • 推荐改变MRI采集协议,强调三维液体衰减反转恢复序列作为核心脑部脉冲序列。
  • 对钆对比剂的使用给出针对特定临床目的的审慎使用建议。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016 Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and monitoring of multiple sclerosis made an important step towards appropriate use of MRI in routine clinical practice. Since their promulgation, there have been substantial relevant advances in knowledge, including the 2017 revisions of the McDonald diagnostic criteria, renewed safety concerns regarding intravenous gadolinium-based contrast agents, and the value of spinal cord MRI for diagnostic, prognostic, and monitoring purposes. These developments suggest a changing role of MRI for the management of patients with multiple sclerosis. This 2021 revision of the previous guidelines on MRI use for patients with multiple sclerosis merges recommendations from the Magnetic Resonance Imaging in Multiple Sclerosis study group, Consortium of Multiple Sclerosis Centres, and North American Imaging in Multiple Sclerosis Cooperative, and translates research findings into clinical practice to improve the use of MRI for diagnosis, prognosis, and monitoring of individuals with multiple sclerosis. We recommend changes in MRI acquisition protocols, such as emphasising the value of three dimensional-fluid-attenuated inversion recovery as the core brain pulse sequence to improve diagnostic accuracy and ability to identify new lesions to monitor treatment effectiveness, and we provide recommendations for the judicious use of gadolinium-based contrast agents for specific clinical purposes. Additionally, we extend the recommendations to the use of MRI in patients with multiple sclerosis in childhood, during pregnancy, and in the post-partum period. Finally, we discuss promising MRI approaches that might deserve introduction into clinical practice in the near future.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Wattjes MP, Ciccarelli O, Reich DS, et al. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021. PMID: 34139157. doi:10.1016/S1474-4422(21)00095-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。